HONG KONG, April 1, 2026 /PRNewswire/ -- The release of Innogen's inaugural annual report following its Hong Kong listing serves not merely as a financial disclosure, but as a strategic ...
Shares of Guangzhou Innogen Pharmaceutical Group soared on their Hong Kong debut, buoyed by strong investor appetite for China’s pharmaceuticals sector, which has enjoyed rising valuations and solid ...
SHANGHAI, July 1 (Reuters) - Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next year, its CEO said on Tuesday, the latest ...
Hosted on MSN
Innogen’s shares almost quadruple in Hong Kong debut amid demand for anti-obesity drugs
Shares of Guangzhou Innogen Pharmaceutical Group soared on their Hong Kong debut, buoyed by strong investor appetite for China’s pharmaceuticals sector, which has enjoyed rising valuations and solid ...
Guangzhou Innogen Pharmaceutical Group Co. plans to take investor orders as soon as this week for its initial public offering in Hong Kong, people familiar with the matter said. The diabetes and ...
Guangzhou Innogen Pharmaceutical Group Co., Ltd OverviewBiotechnology / Healthcare Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drugs. The company's products are used ...
Guangzhou Innogen Pharmaceutical Group Co Ltd is a China-based investment holding company principally engaged in the research, development and commercialisation of pharmaceutical products. The Company ...
Visit a quote page and your recently viewed tickers will be displayed here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results